BioPharm International, January 2023

Accepting Alternative Approaches to Freeze Drying

February 02, 2023

Manufacturing

36

01

Alternative approaches to freeze drying are gaining popularity and will help to overcome some of the challenges associated with conventional lyophilization.

Six Approaches Making the Most Significant Impact in the Future

January 02, 2023

Cover Story

36

01

This compilation allows readers to adjust their thinking to appreciate the full impact certain select technologies will make on the industry by 2026.

Crossing the Same River Multiple Times

January 02, 2023

Special Coverage

36

01

Cautiously setting aside pandemic practices, pharma workers appear ready for flux, change, evolution, and expanding molecular diversity.

Purification of Antibodies Using Novel Convecdiff Membranes Part 1: Providing High Binding Capacity at Short Residence Time and Low Pressure Drops

January 02, 2023

Peer-Reviewed Research

36

01

The testing of new convecdiff membranes shows this material to be well suited for lab- and commercial-scale bind-and-elute applications.

Choosing the Right Resins for Viral Vector Affinity Chromatography

January 02, 2023

Downstream Processing

36

01

Affinity chromatography resins must perform well under mild elution conditions yet withstand robust cleaning and sanitization protocols.

Safeguarding Biologics— Blending Engineering Ingenuity and Managerial Excellence

January 01, 2023

Supply Chain

36

01

Efforts to optimize the ideal blend of technology and best practices that are needed to protect and deliver time- and temperature-sensitive biologic therapies, vaccines, and cell and gene therapies continue to evolve.

Complex Analytical Workflows Increasingly Require Robust Bioassays

January 01, 2023

Analytics

36

01

Biologic drug development requires relevant bioassays to measure and help predict cellular response.

A Rocky Road Ahead for FDA and Industry

January 01, 2023

Regulatory Beat

36

01

Politics and drug shortages will continue to impact FDA and drug manufacturers in 2023.

Creating a Contamination Control Strategy

January 01, 2023

Ask The Expert

36

01

A CCS provides significant benefits to the industry and helps with holistically understanding contamination controls, says Siegfried Schmitt, vice president, Technical at Parexel.

Pedestrians as Priority

January 01, 2023

From the Editor

36

01

Coverage of COVID-19 vaccines was surprisingly displaced by this year’s astounding oncology and iconoclastic gene therapy “cures.”

Paradigm Shift

January 01, 2023

From the CEO

36

01

Cell and gene therapies is unequivocally viewed as the biggest opportunity in the bio/pharma space.